In addition, all B-ALL cases with JAK2 mutations overexpress CRLF2 (type I cytokine receptor subunit, also known as thymic stromal lymphopoietin receptor) (167, 168). The gene discussed is JAK2; the disease is precursor B-cell acute lymphoblastic leukemia.